Clinical Trials Insight: 700035286

Trial Profile

Clinical Trials Insight: 700035286

Phase of Trial: Phase I

Latest Information Update: 15 Jul 2008

At a glance

  • Drugs ICT 111 (Primary)
  • Indications Glioblastoma
  • Focus Adverse reactions
  • Sponsors ImmunoCellular Therapeutics
  • Most Recent Events

    • 15 Jul 2008 New trial record.
    • 09 Jul 2008 This trial is expected to commence in late 2008, subject to FDA clearance.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top